Impairment of the vasodilatation capability of the brachial artery in patients with idiopathic venous thrombosis

Journal of Atherosclerosis and Thrombosis

Volumn 17, Issue 11, 2010, Pages 1190-1198

  Jezovnik, Mateja Kaja ^a   Poredos, Pavel ^a   Stalc, Monika ^a  

^a UNIVERSITY MEDICAL CENTRE LJUBLJANA   (Slovenia)

Author keywords

Circulatory markers of endothelial damage; Dysfunction of venous wall; Endothelial dysfunction; Venous thrombosis

Indexed keywords

GLYCERYL TRINITRATE; PADGEM PROTEIN; VON WILLEBRAND FACTOR;

ADULT; ARTERY BLOOD FLOW; ARTICLE; BRACHIAL ARTERY; CONTROLLED STUDY; DISEASE ASSOCIATION; ECHOGRAPHY; ENDOTHELIAL DYSFUNCTION; FEMALE; HUMAN; IDIOPATHIC VENOUS THROMBOSIS; MAJOR CLINICAL STUDY; MALE; PATHOGENESIS; VASODILATATION; VEIN THROMBOSIS;

EID: 78649877332     PISSN: 13403478     EISSN: 18803873     Source Type: Journal    
DOI: 10.5551/jat.4960     Document Type: Article

References (42)

1. Taddei S, Salvetti A: Endothelial dysfunction in essential hypertension: clinical implications. J Hypertens, 2002; 20: 1671-1674
2. Poredos P: Involvement of Endothelial Dysfunction in Atherogenesis. In: Focus on Atherosclerosis Research 1st Ed., ed by Clark JV, ppl65-183, Nova Science Publishers, Inc., Hauppauge Ny, USA, 2004
3. Migliacci R, Becattini C, Pesavento R, Davi G, Vedovati MC, Guglielmini G, Falcinelli E, Ciabattoni G, Dalla Valle F, Prandoni P, Agnelli G, Gresele P: Endothelial dysfunction in patients with spontaneous venous thrombo-embolism. Haematologica, 2007; 92: 812-818
4. Poredos P, Kek A: Relation of blunted dilation of the bra-chial artery in insulin-dependent diabetes mellitus to microalbuminuria. Am J Cardiol, 2000; 86: 364-367
5. Campia U, Choucair WK, Bryant MB, Waclawiw MA, Cardillo C, Panza JA: Reduced endothelium-dependent and -independent dilation of conductance arteries in African Americans. J Am Coll Cardiol, 2002; 40: 754-760
6. Goldhaber SZ, Grodstein F, Stampfer MJ, Manson JE, Colditz GA, Speizer FE, Willett WC, Hennekens CH: A prospective study of risk factors for pulmonary embolism in women. JAMA, 1997; 277: 642-645
7. Vaya A, Mira Y, Ferrando F, Contreras M, Estelles A, Espana F, Corella D, Aznar J: Hyperlipidaemia and venous thromboembolism in patients lacking thrombo-philic risk factors. Br J Haematol, 2002; 118: 255-259
8. Prandoni P, Bilora F, Marchiori A, Bernardi E, Petrobelli F, Lensing AW, Prins MH, Girolami A: An association between atherosclerosis and venous thrombosis. N Engl J Med, 2003; 348: 1435-1441
9. Libertiny G, Hands L: Deep venous thrombosis in peripheral vascular disease. Br J Surg, 1999; 86: 907-910
10. Bova C, Marchiori A, Noto A, Rossi V, Daniele F, Santoro C, Ricchio R, De Lorenzo R, Umbaca R, Prandoni P: Incidence of arterial cardiovascular events in patients with idiopathic venous thromboembolism. A retrospective cohort study. Thromb Haemost, 2006; 96: 132-136
11. Grady D, Wenger NK, Herrington D, Khan S, Furberg C, Hunninghake D, Vittinghoff E, Hulley S: Postmeno-pausal hormone therapy increases risk for venous throm-boembolic disease. The Heart and Estrogen/progestin Replacement Study. Ann Intern Med, 2000; 132: 689-696
12. Libby P, Simon DI, Ridker PM: Inflammation and ath-erothrombosis. In: Hemostatis and thrombosis: basic principles and clinical practice 5th Ed., ed by Colman RW, Marder VJ, Clowes AW, George JN, pp795-812, Lippincott Williams & Wilkins, Philadelphia, USA, 2006
13. Corretti MC, Anderson TJ, Benjamin EJ, Celermajer D, Charbonneau F, Creager MA, Deanfield J, Drexler H, Gerhard-Herman M, Herrington D, Variance P, Vita J, Vogel R: Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery: a report of the International Brachial Artery Reactivity Task Force. J Am Coll Cardiol, 2002; 39: 257-265
14. Sorensen KE, Celermajer DS, Spiegelhalter DJ, Georga-kopoulos D, Robinson J, Thomas O, Deanfield JE: Non-invasive measurement of human endothelium dependent arterial responses: accuracy and reproducibility. Br Heart J, 1995; 74: 247-253
15. Celermajer DS: Noninvasive detection of atherosclerosis. N Engl J Med, 1998;339:2014-2015
16. Leeson P, Thome S, Donald A, Mullen M, Clarkson P, Deanfield J: Non-invasive measurement of endothelial function: effect on brachial artery dilatation of graded endothelial dependent and independent stimuli. Heart, 1997; 78: 22-27
17. Poredos P: Endothelial dysfunction and cardiovascular disease. Pathophysiol Haemost Thromb, 2002; 32: 274-277
18. Juonala M, Kahonen M, Laitinen T, Hutri-Kahonen N, Jokinen E, Taittonen L, Pietikainen M, Helenius H, Viikari JS, Raitakari OT Effect of age and sex on carotid intima-media thickness, elasticity and brachial endothelial function in healthy adults: the cardiovascular risk in Young Finns Study. Eur Heart J, 2008; 29: 1198-1206
19. Yeboah J, Folsom AR, Burke GL, Johnson C, Polak JF, Post W, Lima JA, Crouse JR, Herrington DM: Predictive value of brachial flow-mediated dilation for incident cardiovascular events in a population-based study: the multiethnic study of atherosclerosis. Circulation, 2009; 120: 502-509
20. Benjamin EJ, Larson MG, Keyes MJ, Mitchell GF, Vasan RS, Keaney JF Jr, Lehman BT, Fan S, Osypiuk E, Vita JA: Clinical correlates and heritability of flow-mediated dilation in the community: the Framingham Heart Study. Circulation, 2004; 109: 613-619
21. Brevetti G, Silvestro A, Schiano V, Chiariello M: Endothelial dysfunction and cardiovascular risk prediction in peripheral arterial disease: additive value of flow-mediated dilation to ankle-brachial pressure index. Circulation, 2003; 108: 2093-2098
22. Khare A, Shetty S, Ghosh K, Mohanty D, Chatterjee S: Evaluation of markers of endothelial damage in cases of young myocardial infarction. Atherosclerosis, 2005; 180: 375-380
23. Blann AD: Plasma von Willebrand factor, thrombosis, and the endothelium: the first 30 years. Thromb Haemost, 2006; 95: 49-55
24. Jansson JH, Nilsson TK, Johnson O: von Willebrand factor in plasma: a novel risk factor for recurrent myocardial infarction and death. Br Heart J, 1991; 66: 351-355
25. Cortellaro M, Boschetti C, Cofrancesco E, Zanussi C, Catalano M, de Gaetano G, Gabrielli L, Lombardi B, Specchia G, Tavazzi L, Tremoli E, della Volpe A, Polli E, the PLAT Study Group: Hemostatic function in relation to atherothrombotic ischemic events in vascular disease patients. Principal results. PLAT Study Group. Progetto Lombardo Atero-Trombosi (PLAT) Study Group. Arte-rioscler Thromb, 1992; 12: 1063-1070
26. Li-Saw-Hee FL, Blann AD, Lip GY: Effects of fixed low-dose warfarin, aspirin-warfarin combination therapy, and dose-adjusted warfarin on thrombogenesis in chronic atrial fibrillation. Stroke, 2000; 31: 828-833
27. Chong AY, Chin BS, Blann AD, Lip GY: Effects of anti-platelet therapy and oral anticoagulation on indices of endothelial damage/dysfunction in patients with systolic heart failure in sinus rhythm. Thromb Res, 2005; 116: 181-183
28. Cambien B, Wagner DD: A new role in hemostasis for the adhesion receptor P-selectin. Trends Mol Med, 2004; 10: 179-186
29. Furie B, Furie BC: Role of platelet P-selectin and mic-roparticle PSGL-1 in thrombus formation. Trends Mol Med, 2004; 10: 171-178
30. Polgar J, Matuskova J, Wagner DD: The P-selectin, tissue factor, coagulation triad. J Thromb Haemost, 2005; 3: 1590-1596
31. Vandendries ER, Furie BC, Furie B: Role of P-selectin and PSGL-1 in coagulation and thrombosis. Thromb Haemost, 2004; 92: 459-466
32. Myers DD, Hawley AE, Farris DM, Wrobleski SK, Tha-naporn P, Schaub RG, Wagner DD, Kumar A, Wakefield TW: P-selectin and leukocyte microparticles are associated with venous thrombogenesis. J Vase Surg, 2003; 38: 1075-1089
33. Smith A, Quarmby JW, Collins M, Lockhart SM, Bur-nand KG: Changes in the levels of soluble adhesion molecules and coagulation factors in patients with deep vein thrombosis. Thromb Haemost, 1999; 82: 1593-1599
34. Rectenwald JE, Myers DD Jr, Hawley AE, Longo C, Henke PK, Guire KE, Schmaier AH, Wakefield TW: D-dimer, P-selectin, and microparticles: novel markers to predict deep venous thrombosis. A pilot study. Thromb Haemost, 2005; 94: 1312-1317
35. Blann AD, Noteboom WM, Rosendaal FR: Increased soluble P-selectin levels following deep venous thrombosis: cause or effect? Br J Haematol, 2000; 108: 191-193
36. Ay C, Simanek R, Vormittag R, Dunkler D, Alguel G, Koder S, Kornek G, Marosi C, Wagner O, Zielinski C, Pabinger I: High plasma levels of soluble P-selectin are predictive of venous thromboembolism in cancer patients: results from the Vienna Cancer and Thrombosis Study (CATS). Blood, 2008; 112: 2703-2708
37. Semenov AV, Romanov YA, Loktionova SA, Tikhomirov OY, Khachikian MV, Vasil'ev SA, Mazurov AV: Production of soluble P-selectin by platelets and endothelial cells. Biochemistry (Mosc), 1999; 64: 1326-1335
38. Fijnheer R, Frijns CJ, Korteweg J, Rommes H, Peters JH, Sixma JJ, Nieuwenhuis HK: The origin of P-selectin as a circulating plasma protein. Thromb Haemost, 1997; 77: 1081-1085
39. Kamath S, Blann AD, Caine GJ, Gurney D, Chin BS, Lip GY: Platelet P-selectin levels in relation to plasma soluble P-selectin and beta-thromboglobulin levels in atrial fibrillation. Stroke, 2002; 33: 1237-1242
40. Hodgson JM, Puddey IB, Burke V, Watts GF, Beilin LJ: Regular ingestion of black tea improves brachial artery vasodilator function. Clin Sci (Lond), 2002; 102: 195-201
41. Huellner MW, Schrepfer S, Weyand M, Weiner H, Wim-plinger I, Eschenhagen T, Rau T: Inhibition of aldehyde dehydrogenase type 2 attenuates vasodilatory action of nitroglycerin in human veins. FASEB J, 2008; 22: 2561-2568
42. Kearney MF, Brien JF, Marks GS, Lei H, Nakatsu K: Thiol agents separate nitric oxide formation from vasodi-lation induced by glyceryl trinitrate. Drug Metab Dispos, 1998; 26: 547-551